SERA PROGNOSTICS, INC. (SERA) Stock Price, Financials & Summary

Price chart

Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19

Key dataOct 19, 2026

Open$2.07

From 52W high−45.87%

Volume5281.00

Market cap$80.08M

P/E (TTM)—

P/S (TTM)1144.0x

Div yield—

Key dataOct 19, 2026

Open

$2.07

From 52W high

−45.87%

Volume

5281.00

Market cap

$80.08M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−1.1x

P/E (TTM)

—

RSI (14)

51.0

MomentumView details →

1D Return

−1.46%

YTD Return

−30.17%

SummaryUpdated Jun 1, 2026

Sera Prognostics, Inc. (NASDAQ:SERA) is a women's health diagnostic company founded in 2008 and headquartered in Salt Lake City, Utah. The company went public in July 2021 and focuses on developing blood-based biomarker tests to predict and improve pregnancy outcomes. Sera Prognostics operates in the specialized field of prenatal diagnostics, addressing one of healthcare's most pressing challenges: preterm birth, which affects approximately 1 in 10 babies born in the United States and has seen rates increase by 12% between 2014-2022.

Ask drillr about SERA PROGNOSTICS, INC. →

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−1.1x

EV/Sales

523.4x

P/S (TTM)

1144.0x

P/B (TTM)

1.3x

ProfitabilityView details →

Gross Margin

−150.00%

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−55.97%

ROA (TTM)

−38.31%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

−35.19%

EPS YoY

+21.18%

FCF YoY

−4.46%

Revenue CAGR 3Y

−32.89%

EPS CAGR 3Y

+32.32%

EBITDA YoY

−1.59%

MomentumView details →

1D Return

−1.46%

YTD Return

−30.17%

1Y Return

−38.87%

RSI (14)

51.0

vs 50D SMA

+0.65%

vs 200D SMA

−5.95%

Capital & dividendView details →

Debt/Equity

0.05x

Current Ratio

1.98x

Quick Ratio

1.98x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.18

EPS Surprise

−16.72%

Beats (12Q)

7/12

Next Q EPS Est

−$0.17

Avg Surprise (4Q)

2.35%

Rev Surprise

−57.97%

Financials snapshotView financials →

Revenue (TTM)

70000.00

Net Income (TTM)

−33.23M

Op. CF (TTM)

−27.68M

Next earningsNov 12, 2026 →

Latest newsMore news →

Sera Prognostics, Inc. announced the appointment of Scott Gleason as Chief Financial Officer and Treasurer, effective August 31, 2026.62d ago

Sera Prognostics, Inc. held its Q2 2026 earnings call on August 12, 2026, discussing financial results and business updates.68d ago

Similar companies

China Health Group Inc.08225.HK Atlantic International Corp.ATLN Burning Rock Biotech LimitedBNR Neuronetics, Inc.STIM DarioHealth Corp.DRIO Precipio, Inc.PRPO Find similar companies →

Latest newsMore news →

Sera Prognostics, Inc. announced the appointment of Scott Gleason as Chief Financial Officer and Treasurer, effective August 31, 2026.62d ago Sera Prognostics, Inc. held its Q2 2026 earnings call on August 12, 2026, discussing financial results and business updates.68d ago